Acute disseminated encephalomyelitis: A follow-up study in Taiwan

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 2, 2007, Pages 162-167

  Lin, C H ^a   Jeng, J S ^a   Hsieh, S T ^a   Yip, P K ^a   Wu, R M ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; LEVAMISOLE; RUBELLA VACCINE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENCEPHALOMYELITIS; EXPANDED DISABILITY STATUS SCALE; FEMALE; FEVER; FOLLOW UP; HUMAN; IMMUNIZATION; MALE; MENTAL DISEASE; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; RADIODIAGNOSIS; TAIWAN; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; TAIWAN;

EID: 33846860205     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.084194     Document Type: Article

References (26)

1. Jarousse N, Viktorova EG, Pilipenko EV, et al. An attenuated variant of the GDVII strain of Theiler's virus does not persist and infect the white matter of the central nervous system. J Virol 1999;73:801-4.
2. Tolley ND, Tsunoda I, Fujinami RS. DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J Virol 1999;73:993-1000.
3. Jorens PG, VanderBorght A, Ceulemans B, et al. Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology 2000;54:1433-41.
4. Leake AD, Albani S, Kao AS, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis 2004;23:756-64.
5. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002;59:1224-31.
6. Dale RC, de Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-22.
7. Mikaeloff Y, Suissa S, Vallée L, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004;144:246-52.
8. Schwarz S, Mohr A, Knauth M, et al. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001;56:1313-18.
9. Murthy JM, Yangala R, Meena AK, et al. Clinical, electrophysiological and magnetic imaging study of acute disseminated encephalomyelitis. J Assoc Physicians India 1999;47:280-3.
10. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444- 52.
11. Rankin J. Cerebral vascular accidents in patients over the age of 60: prognosis. Scott Med J 1957;2:200-15.
12. Lin CH, Jeng JS, Yip PK. Plasmapheresis in acute disseminated encephalomyelitis. J Clin Apheresis 2004;19:154-9.
13. Poser CM, Paly DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
14. Hook CC, Kimmel DW, Kvols LK, et al. Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 1992;31:262-7.
15. Savarese DM, Gordon J, Smith TW, et al. Cerebral demyelination syndrome in a patient treated with 5-fluorouracil and levamisole. Cancer 1996;77:387-94.
16. Moertel CG, Fleming TR, MacDonal JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-9.
17. Sun A, Chia JS, Chang YF, et al. Levamisole and Chinese medical herbs can modulate the serum interleukin-6 level in patients with recurrent aphthous ulcerations. J Oral Pathol Med 2003;32:206-14.
18. Stevenson HC, Green I, Hamilton JM, et al. Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer. J Clin Oncol 1999;9:2052-66.
19. Kira JI. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2:117-27.
20. Hynson JL, Komberg AJ, Coleman LT, et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001;56:1308-12.
21. Kimura S, Nezu A, Ohtsuki N, et al. Serial magnetic resonance imaging in children with postinfectious encephalitis. Brain Dev 1996;18:461-5.
22. Mader I, Stock KW, Ettlin T, et al. Acute disseminated encephalomyelitis: MR and CT features. Am J Neuroradiol 1996;17:104-9.
23. Boutin B, Esquivel E, Moyer M, et al. Multiple sclerosis in children: report of clinical and paraclinical features of 19 cases. Neuropediatrics 1988;19:118-23.
24. Sindern E, Haas J, Stark E, et al. Early onset MS under the age of 16: clinical and paraclinical features. Acta Neurol Scand 1992;86:280-4.
25. Matejuk A, Hopke C, Vandenbark AA, et al. Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy. J Immunol 2005;174:2387- 95.
26. Fulop T, Larbi A, Wikby A, et al. Dysregulatron of T-cell function in the elderly: scientific basis and clinical implications. Drugs Aging 2005;22:589-603.